Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

[Prognostic value of PET/CT in lung cancer: retrospective analysis of 47 patients].

de Guevara DL, Fuentes A, Fariña C, Corral C, Pefaur R.

Rev Med Chil. 2013 Jan;141(1):41-8. doi: 10.4067/S0034-98872013000100006. Spanish.

2.

[Positron emission tomography/computed tomography for lung cancer staging].

Ladrón de Guevara H D, Furnaro L F, Yévenes A S, Clavero R JM, Lazo P D, Rodríguez D P, Piottante B A, Pefaur D R, Pardo B C.

Rev Med Chil. 2015 Jan;143(1):22-9. doi: 10.4067/S0034-98872015000100003. Spanish.

3.

Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.

Saydam O, Gokce M, Kilicgun A, Tanriverdi O.

Med Oncol. 2012 Jun;29(2):589-94. doi: 10.1007/s12032-011-9879-y. Epub 2011 Mar 6.

PMID:
21380783
4.

False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.

Gómez-Caro A, Boada M, Cabañas M, Sanchez M, Arguis P, Lomeña F, Ramirez J, Molins L.

Eur J Cardiothorac Surg. 2012 Jul;42(1):93-100; discussion 100. doi: 10.1093/ejcts/ezr272. Epub 2012 Jan 20.

PMID:
22290911
5.

The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.

Lu P, Sun Y, Sun Y, Yu L.

Lung Cancer. 2014 Jul;85(1):53-8. doi: 10.1016/j.lungcan.2014.04.004. Epub 2014 Apr 18.

PMID:
24792334
6.

Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.

Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.

Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.

PMID:
22999369
7.

Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2012 Dec;144(6):1365-71. doi: 10.1016/j.jtcvs.2012.07.012. Epub 2012 Aug 9.

8.

Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.

Billè A, Okiror L, Skanjeti A, Errico L, Arena V, Penna D, Ardissone F, Pelosi E.

Eur J Cardiothorac Surg. 2013 Mar;43(3):574-9. doi: 10.1093/ejcts/ezs366. Epub 2012 Jun 11.

PMID:
22689182
9.

PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.

Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roqué I Figuls M.

Cochrane Database Syst Rev. 2014 Nov 13;(11):CD009519. doi: 10.1002/14651858.CD009519.pub2. Review.

PMID:
25393718
10.

Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.

Onal C, Oymak E, Findikcioglu A, Reyhan M.

Int J Gynecol Cancer. 2013 Feb;23(2):337-42. doi: 10.1097/IGC.0b013e31827e00cc.

PMID:
23358181
11.

Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.

Aristophanous M, Berbeco RI, Killoran JH, Yap JT, Sher DJ, Allen AM, Larson E, Chen AB.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e99-105. doi: 10.1016/j.ijrobp.2010.12.060. Epub 2011 Mar 4.

PMID:
21377285
13.

Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.

Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.

Acta Radiol. 2009 Jul;50(6):638-44. doi: 10.1080/02841850902971255.

PMID:
19492198
14.

[Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].

Shao T, Yu L, Li Y, Chen M.

Zhongguo Fei Ai Za Zhi. 2015 Mar;18(3):155-60. doi: 10.3779/j.issn.1009-3419.2015.03.05. Chinese.

15.

Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.

Nakamura H, Saji H, Marushima H, Kimura H, Tagaya R, Kurimoto N, Hoshikawa M, Takagi M.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1388-93. doi: 10.1245/s10434-015-4564-6. Epub 2015 Apr 22.

PMID:
25900205
16.

Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using ¹⁸F-FDG PET/CT.

Park B, Kim HK, Choi YS, Kim J, Zo JI, Choi JY, Shim YM.

Korean J Radiol. 2015 Jul-Aug;16(4):929-35. doi: 10.3348/kjr.2015.16.4.929. Epub 2015 Jul 1.

17.

Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?

Ito R, Iwano S, Kishimoto M, Ito S, Kato K, Naganawa S.

Ann Nucl Med. 2015 Dec;29(10):897-905. doi: 10.1007/s12149-015-1025-z. Epub 2015 Sep 5.

PMID:
26342592
18.
19.

Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.

Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.

Biomed Mater Eng. 2014;24(6):3091-103. doi: 10.3233/BME-141131.

PMID:
25227018
20.

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.

Schaarschmidt BM, Buchbender C, Nensa F, Grueneisen J, Gomez B, Köhler J, Reis H, Ruhlmann V, Umutlu L, Heusch P.

PLoS One. 2015 Jan 9;10(1):e0116277. doi: 10.1371/journal.pone.0116277. eCollection 2015. Erratum in: PLoS One. 2015;10(3):e0120606. Grueneien, Johannes [corrected to Grueneisen, Johannes]. PLoS One. 2015;10(3):e0122545.

Supplemental Content

Support Center